Fangzhou Jianke Successfully Listed in Guangzhou's AI and Big Data Enterprise Database, Recognized for Technical Excellence and Data Capabilities
In response to national policies and guidelines, and to implement work deployments such as the “Three-Year Action Plan for Building the Guangzhou Artificial Intelligence and Digital Economy Pilot Zone (2020–2022),” the Guangzhou Municipal Bureau of Industry and Information Technology commissioned the Guangzhou Association for the Promotion of Artificial Intelligence Industry Development to organize the routine inclusion of big data/artificial intelligence enterprises in Guangzhou’s enterprise database for 2021–2022.
Following expert review, Guangzhou Fangzhou Information Technology Co., Ltd., a subsidiary of Fangzhou Jianke Group, has been successfully selected as a leading enterprise in core AI-driven internet healthcare technologies within the industry.
According to the latest data, Guangzhou has 567 AI companies in its database, among which 13 have been recognized as provincial key AI enterprises, accounting for nearly half of the province's total.
The listed companies cover six core business areas: foundational support for artificial intelligence, core technologies, industry applications, foundational support for big data, data services, and integrated applications. Of these companies, 68% report annual revenues exceeding RMB 10 million. The total investment in the reserve projects reaches RMB 12 billion, with annual R&D expenditure totaling RMB 7.6 billion. The cumulative number of invention patents held by the listed companies stands at 5,200.
In recent years, with the rapid development of the internet healthcare industry, corresponding technological methods have been continuously iterated and innovated. Fangzhou Jianke has leveraged technologies such as computer vision, recommendation algorithms, knowledge graphs, cloud computing, and blockchain to drive innovations in relationship connectivity, interactive diagnosis and treatment, and pharmaceutical services. This approach establishes familiar doctor-patient relationships within internet-based chronic disease management services. Furthermore, by integrating big data analytics and artificial intelligence into disease course management, Fangzhou Jianke fosters broader and deeper connections between doctors and patients, delivering more effective health management and innovative treatment plans to patients.
Fangzhou Jianke leverages its mature digital capabilities to deliver comprehensive, multi-touchpoint chronic disease management services directly to patients. By breaking down temporal and spatial barriers through digital means, Fangzhou Jianke enables physicians to fully utilize their expertise within their respective specialties while providing patients with a closed-loop internet healthcare service ecosystem encompassing “medical care, patient engagement, pharmaceuticals, insurance, and health knowledge.”
Currently, through Fangzhou Jianke’s apps—Jianke Doctor and Jianke Hospital—patients can not only access professional health education materials but also communicate in real time with specialists and physicians. Meanwhile, doctors can obtain patients’ latest diagnostic and treatment data, formulate more targeted care plans based on changes in their condition, improve medication adherence, and facilitate a shift in chronic disease management from treatment-oriented to prevention-oriented scenarios and services.
Founded in 2009, Ark Health is committed to its mission of “Making Everyone Healthier.” By focusing on advancing internet-based chronic disease management services, it has grown into a leading full-lifecycle chronic disease management service platform in China. The company has established a closed-loop internet chronic disease service ecosystem supported by its online hospital, one-stop chronic disease management service centers, new media center, and online pharmacy.
During this period, Fangzhou Jianke innovatively constructed an H2H (Hospital-to-Home) smart healthcare business ecosystem, advocating for the gradual extension of medical services, chronic disease management, doctor-patient education, and pharmaceutical services from hospitals to patients’ homes. This approach enables home-based disease management, improves patients’ healthcare experiences, enhances the timeliness of medical services and the accessibility of pharmaceutical services, and provides chronic disease patients with exclusive, personalized services featuring the characteristics of professional online family doctors.